Combining Immunotherapy with Stereotactic Radiotherapy: A Paradigm Shift?

Centerline

In a VarianVision webinar held in early 2021, expert oncologists from the University of California at San Diego Moores Cancer Center discussed how advances in combining immunotherapy with stereotactic radiotherapy may be leading to a paradigm shift in the...

Read more

Multidisciplinary Cancer Care: What Does the Future Hold?

Centerline

The use of multidisciplinary collaboration through tumor boards leads to changes in diagnosis, treatment, and survival, and it is the best way to deliver the complex care needed by cancer patients, according to recently published long-term research.

Read more

New Study Highlights Patient Satisfaction and Clinical Feasibility of Noona

Centerline

A clinical trial using Varian’s Noona® solution for patient engagement assesses the impact of ePROs on healthcare utilization and clinical burden.

Read more

Expanded Intracranial Applications for HyperArc Therapy

Centerline

Introduced in 2017 to help simplify SRS treatment planning and delivery for multiple brain metastases, HyperArc high-definition radiosurgery is now proving effective at treating benign intracranial lesions.

Read more

An Industry/Academic Partnership Yields Fruit: An Ultra-High Dose Rate Beam Monitoring Tool for FLASH Trials

Centerline

Varian, in partnership with the Danish Centre for Particle Therapy (DCPT) at Aarhus University Hospital and the Cincinnati Children’s Hospital/UC Health Proton Therapy Center—two members of the FlashForward™ Consortium—has tested a specialized dose monito...

Read more

Adaptive Radiotherapy Post-COVID: An Interview with Professor Patricia Price

Centerline

As many facilities move back towards normal operations after COVID restrictions, Professor Pat Price, a leading expert on radiation oncology, discusses what that means for adaptive radiotherapy.

Read more

Royal Surrey NHS Foundation Trust, Guildford, UK: Focusing on Patients Who Will Benefit Most

Centerline

The Royal Surrey County Hospital comprises two sites about 20 miles apart in the county of Surrey, UK. Across the two sites, radiotherapy clinicians treat about 3,500 patients a year, typically with IMRT or RapidArc® radiotherapy, including stereotactic a...

Read more

Henry Ford Cancer Institute (HFCI), Michigan: Looking Towards Adaptation During Five-Fraction SBRT

Centerline

Henry Ford Allegiance (HFA) is a community-based hospital about 60 miles west of the main Henry Ford Health System campus. Its HFCI radiation oncology clinic treats approximately 450 patients a year, with more than 9,000 external beam treatments delivered...

Read more

Royal North Shore Hospital, Sydney, Australia: Adapting to Changes in the Target

Centerline

The Royal North Shore Hospital in Sydney, Australia, also deployed its Ethos™ therapy system about a year ago. Royal North Shore is a small, state-funded facility that treats about 1,500 cancer patients a year and its head of medical physics, Assistant P...

Read more